NPI: 1548299373 · EAST ORANGE, NJ 07017 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 07/02/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 07/02/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 14,848 | $1.01M |
| 2019 | 15,439 | $1.13M |
| 2020 | 15,661 | $921K |
| 2021 | 12,841 | $623K |
| 2022 | 25,606 | $593K |
| 2023 | 17,956 | $236K |
| 2024 | 10,086 | $387K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 47,616 | 3,317 | $3.61M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 19,340 | 1,288 | $595K |
| J1270 | Injection, doxercalciferol, 1 mcg | 15,990 | 1,272 | $342K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 391 | 210 | $63K |
| J1756 | Injection, iron sucrose, 1 mg | 6,109 | 1,195 | $62K |
| A4657 | Syringe, with or without needle, each | 8,103 | 2,016 | $52K |
| 85041 | 1,646 | 1,226 | $31K | |
| 83970 | 1,417 | 1,038 | $31K | |
| 85048 | 1,628 | 1,210 | $30K | |
| 82728 | 773 | 605 | $23K | |
| 83540 | 762 | 604 | $23K | |
| 83550 | 579 | 499 | $23K | |
| 82108 | 396 | 320 | $13K | |
| 90662 | 12 | 12 | $869.84 | |
| G0008 | Administration of influenza virus vaccine | 95 | 84 | $869.84 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 184 | 125 | $1.56 |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,118 | 434 | $0.00 |
| OP250 | 6,249 | 271 | $0.00 | |
| 90674 | 29 | 25 | $0.00 |